infraorbital dark circle. Chloasma of eyelid and periocular area
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: People 18 to 50 years old with dark circles around the eyes
Exclusion criteria
Exclusion criteria: Pregnant women and breastfeeding mothers Taking oral contraceptive pills during the last 12 months and during the study Existence of any history of coagulation disorders and thrombotic problemsCommunity Verified icon Taking anticoagulants Existence of allergy to the studied drugs and topical lidocaine History of dark circles treatment around the eyes during the last six months Hereditary or acquired connective tissue diseases History of colloidal scarring History of isotretinoin use within one year before treatment
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Percentage of improvement of opacity after 3 sessions of treatment. Timepoint: It is done at the beginning of the study and weeks 2, 4, 8 and 12. Method of measurement: ??? ?????? ?? ??????. | — |
Countries
Iran (Islamic Republic of)
Contacts
Ahvaz University of Medical Sciences